Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Genetic variants in apolipoprotein L1 (APOL1) confer risk for kidney disease. We sought to better define the phenotype of APOL1-associated nephropathy. The FSGS Clinical Trial involved 138 children and young adults who were randomized to cyclosporin or mycophenolate mofetil plus pulse oral dexamethasone with a primary outcome of proteinuria remission. DNA was available from 94 subjects who were genotyped for APOL1 renal risk variants, with two risk alleles comprising the risk genotype. Two APOL1 risk alleles were present in 27 subjects, of whom four subjects did not self-identify as African American, and 23 of 32 (72%) self-identified African Americans. Individuals with the APOL1 risk genotype tended to present at an older age and had significantly lower baseline eGFR, more segmental glomerulosclerosis and total glomerulosclerosis, and more tubular atrophy/interstitial fibrosis. There were differences in renal histology, particularly more collapsing variants in those with the risk genotype (P=0.02), although this association was confounded by age. APOL1 risk genotype did not affect response to either treatment regimen. Individuals with the risk genotype were more likely to progress to ESRD (P<0.01). In conclusion, APOL1 risk genotypes are common in African-American subjects with primary FSGS and may also be present in individuals who do not self-identify as African American. APOL1 risk status is associated with lower kidney function, more glomerulosclerosis and interstitial fibrosis, and greater propensity to progress to ESRD. The APOL1 risk genotype did not influence proteinuria responses to cyclosporin or mycophenolate mofetil/dexamethasone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028
Self-citation
Cited by
Focal Segmental Glomerulosclerosis
Rosenberg, A. Z., & Kopp, J. B. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05960616 · Cited by 562
Self-citationCOVID-19–Associated Kidney Injury: A Case Series of Kidney Biopsy Findings
Sharma, P., Uppal, N. N., Wanchoo, R., Shah, H. H., Yang, Y., Parikh, R., Khanin, Y., Madireddy, V., Larsen, C. P., Jhaveri, K. D., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050699 · Cited by 367
Genetic, environmental, and epigenetic factors involved in CAKUT
Nicolaou, N., Renkema, K. Y., Bongers, E. M. H. F., Giles, R. H., & Knoers, N. V. A. M. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.140 · Cited by 344
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice
Beckerman, P., Bi-Karchin, J., Park, A. S. D., Qiu, C., Dummer, P. D., Soomro, I., Boustany-Kari, C. M., Pullen, S. S., Miner, J. H., Hu, C.-A. A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4287 · Cited by 344
Self-citationDifferentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach
De Vriese, A. S., Sethi, S., Nath, K. A., Glassock, R. J., & Fervenza, F. C. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017090958 · Cited by 318
Metadata
- Authors
- Kopp, J. B., Winkler, C. A., Zhao, X., Radeva, M. K., Gassman, J. J., D’Agati, V. D., Nast, C. C., Wei, C., Reiser, J., Guay-Woodford, L. M., Pollak, M. R., Hildebrandt, F., Moxey-Mims, M., Gipson, D. S., Trachtman, H., Friedman, A. L., & Kaskel, F. J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-06
- Volume
- 26
- Issue
- 6
- Pages
- 1443-1448
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2095763846
- Cited by
- 127
- References
- 1
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial. https://app.cochat.ai/papers/10.1681/asn.2013111242
- The paper
- Kopp, J. B., Winkler, C. A., Zhao, X., Radeva, M. K., Gassman, J. J., D’Agati, V. D., Nast, C. C., Wei, C., Reiser, J., Guay-Woodford, L. M., Pollak, M. R., Hildebrandt, F., Moxey-Mims, M., Gipson, D. S., Trachtman, H., Friedman, A. L., & Kaskel, F. J. (2015). Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2013111242
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.